Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Akari Therapeutics ADR (AKTX)

Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Akari Therapeutics Bolsters Global IP Estate for its Novel Antibody Drug Conjugate (ADC) Immuno-Oncology Payload, PH1, with Recent Granting of Patent Protection Across India GlobeNewswire - Wed Jun 18, 7:50AM CDT

AKTX : 1.1600 (unch)
Akari Therapeutics Releases “Meet the Team” Video Featuring Recently Appointed Mark F. Kubik, Head of Business Development – Oncology GlobeNewswire - Thu May 29, 8:15AM CDT

AKTX : 1.1600 (unch)
Akari Therapeutics to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar GlobeNewswire - Thu May 22, 8:00AM CDT

AKTX : 1.1600 (unch)
Corbus Pharmaceuticals Names Industry Veteran Rachelle Jacques as Board Chair GlobeNewswire - Mon May 19, 7:00AM CDT

AKTX : 1.1600 (unch)
QURE : 14.22 (+1.94%)
CRBP : 7.96 (+0.89%)
Akari Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update GlobeNewswire - Thu May 15, 7:05AM CDT

AKTX : 1.1600 (unch)
Akari Therapeutics Appoints Mark F. Kubik as Head of Business Development - Oncology GlobeNewswire - Thu May 1, 7:45AM CDT

AKTX : 1.1600 (unch)
Akari Therapeutics Releases Welcome Video from Newly Appointed Chief Executive Officer, Abizer Gaslightwala GlobeNewswire - Tue Apr 22, 8:05AM CDT

AKTX : 1.1600 (unch)
Akari Therapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update GlobeNewswire - Wed Apr 16, 7:00AM CDT

AKTX : 1.1600 (unch)
This Micro Cap Continues This Week's Dominance Amid New CEO Appointment Yolowire - Thu Mar 20, 3:19PM CDT

A London-based %Healthcare company found success Thursday after the company announced that it had appointed a new CEO. The new executive is Abizer Gaslightwala, who was most recently senior vice president...

AKTX : 1.1600 (unch)
Akari Therapeutics Appoints Biotechnology Industry Leader, Abizer Gaslightwala, as President and Chief Executive Officer GlobeNewswire - Thu Mar 20, 7:35AM CDT

AKTX : 1.1600 (unch)

Barchart Exclusives

Teladoc Stock Is a ‘Coiled Spring’ That Could Surge Higher. Should You Buy TDOC Here? Barchart - 1 hour ago
Teladoc stock gains as Citron Research posts a bullish report in its favor. Wall Street remains positive on TDOC shares for the second half of 2025 as well. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot